Global Osteoarthritis Therapeutics Market to Reach $11.4 Billion by 2027

Abstract: - Global Osteoarthritis Therapeutics Market to Reach $11. 4 Billion by 2027. - Amid the COVID-19 crisis, the global market for Osteoarthritis Therapeutics estimated at US$7.

New York, Sept. 15, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Osteoarthritis Therapeutics Industry" - https://www.reportlinker.com/p06032411/?utm_source=GNW
1 Billion in the year 2020, is projected to reach a revised size of US$11.4 Billion by 2027, growing at a CAGR of 6.9% over the analysis period 2020-2027. Knee, one of the segments analyzed in the report, is projected to record a 7.6% CAGR and reach US$5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Hip segment is readjusted to a revised 6.9% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $1.9 Billion, While China is Forecast to Grow at 10.5% CAGR
- The Osteoarthritis Therapeutics market in the U.S. is estimated at US$1.9 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.5 Billion by the year 2027 trailing a CAGR of 10.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.7% and 6.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.
- Hand Segment to Record 6.1% CAGR
- In the global Hand segment, USA, Canada, Japan, China and Europe will drive the 5.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.1 Billion in the year 2020 will reach a projected size of US$1.6 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.5 Billion by the year 2027, while Latin America will expand at a 7.3% CAGR through the analysis period.

- Select Competitors (Total 34 Featured) -

• Abbott

• Anika Therapeutics

• Bayer AG

• Bioventus

• Eli Lilly

• Fidia Farmaceutici s.p.a.

• Flexion Therapeutics

• GlaxoSmithKline Plc

• Horizon Therapeutics

• Johnson & Johnson

• Novartis

• Pfizer

• Sanofi

• Zimmer Biomet Holdings, Inc.

Read the full report: https://www.reportlinker.com/p06032411/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Osteoarthritis
Therapeutics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Osteoarthritis Therapeutics
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Osteoarthritis
Therapeutics by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets for
Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Knee by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 5: World Historic Review for Knee by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Knee by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Hip by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 8: World Historic Review for Hip by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Hip by Geographic Region -
Percentage Breakdown of Value Sales for USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Hand by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 11: World Historic Review for Hand by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Hand by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Small Joints by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 14: World Historic Review for Small Joints by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 15: World 15-Year Perspective for Small Joints by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for
Viscosupplementation Agents by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Viscosupplementation Agents
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Viscosupplementation
Agents by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 19: World Current & Future Analysis for Nonsteroidal
Anti-inflammatory Drugs by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Nonsteroidal
Anti-inflammatory Drugs by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Nonsteroidal
Anti-inflammatory Drugs by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027

Table 22: World Current & Future Analysis for Analgesics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 23: World Historic Review for Analgesics by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 24: World 15-Year Perspective for Analgesics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Corticosteroids
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 26: World Historic Review for Corticosteroids by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for Corticosteroids by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 28: USA Current & Future Analysis for Osteoarthritis
Therapeutics by Anatomy - Knee, Hip, Hand and Small Joints -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 29: USA Historic Review for Osteoarthritis Therapeutics
by Anatomy - Knee, Hip, Hand and Small Joints Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 30: USA 15-Year Perspective for Osteoarthritis
Therapeutics by Anatomy - Percentage Breakdown of Value Sales
for Knee, Hip, Hand and Small Joints for the Years 2012, 2020 &
2027

Table 31: USA Current & Future Analysis for Osteoarthritis
Therapeutics by Drug Type - Viscosupplementation Agents,
Nonsteroidal Anti-inflammatory Drugs, Analgesics and
Corticosteroids - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 32: USA Historic Review for Osteoarthritis Therapeutics
by Drug Type - Viscosupplementation Agents, Nonsteroidal
Anti-inflammatory Drugs, Analgesics and Corticosteroids Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 33: USA 15-Year Perspective for Osteoarthritis
Therapeutics by Drug Type - Percentage Breakdown of Value Sales
for Viscosupplementation Agents, Nonsteroidal Anti-inflammatory
Drugs, Analgesics and Corticosteroids for the Years 2012, 2020 &
2027

CANADA
Table 34: Canada Current & Future Analysis for Osteoarthritis
Therapeutics by Anatomy - Knee, Hip, Hand and Small Joints -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 35: Canada Historic Review for Osteoarthritis
Therapeutics by Anatomy - Knee, Hip, Hand and Small Joints
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 36: Canada 15-Year Perspective for Osteoarthritis
Therapeutics by Anatomy - Percentage Breakdown of Value Sales
for Knee, Hip, Hand and Small Joints for the Years 2012, 2020 &
2027

Table 37: Canada Current & Future Analysis for Osteoarthritis
Therapeutics by Drug Type - Viscosupplementation Agents,
Nonsteroidal Anti-inflammatory Drugs, Analgesics and
Corticosteroids - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 38: Canada Historic Review for Osteoarthritis
Therapeutics by Drug Type - Viscosupplementation Agents,
Nonsteroidal Anti-inflammatory Drugs, Analgesics and
Corticosteroids Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 39: Canada 15-Year Perspective for Osteoarthritis
Therapeutics by Drug Type - Percentage Breakdown of Value Sales
for Viscosupplementation Agents, Nonsteroidal Anti-inflammatory
Drugs, Analgesics and Corticosteroids for the Years 2012, 2020 &
2027

JAPAN
Table 40: Japan Current & Future Analysis for Osteoarthritis
Therapeutics by Anatomy - Knee, Hip, Hand and Small Joints -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 41: Japan Historic Review for Osteoarthritis Therapeutics
by Anatomy - Knee, Hip, Hand and Small Joints Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 42: Japan 15-Year Perspective for Osteoarthritis
Therapeutics by Anatomy - Percentage Breakdown of Value Sales
for Knee, Hip, Hand and Small Joints for the Years 2012, 2020 &
2027

Table 43: Japan Current & Future Analysis for Osteoarthritis
Therapeutics by Drug Type - Viscosupplementation Agents,
Nonsteroidal Anti-inflammatory Drugs, Analgesics and
Corticosteroids - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 44: Japan Historic Review for Osteoarthritis Therapeutics
by Drug Type - Viscosupplementation Agents, Nonsteroidal
Anti-inflammatory Drugs, Analgesics and Corticosteroids Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 45: Japan 15-Year Perspective for Osteoarthritis
Therapeutics by Drug Type - Percentage Breakdown of Value Sales
for Viscosupplementation Agents, Nonsteroidal Anti-inflammatory
Drugs, Analgesics and Corticosteroids for the Years 2012, 2020 &
2027

CHINA
Table 46: China Current & Future Analysis for Osteoarthritis
Therapeutics by Anatomy - Knee, Hip, Hand and Small Joints -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 47: China Historic Review for Osteoarthritis Therapeutics
by Anatomy - Knee, Hip, Hand and Small Joints Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 48: China 15-Year Perspective for Osteoarthritis
Therapeutics by Anatomy - Percentage Breakdown of Value Sales
for Knee, Hip, Hand and Small Joints for the Years 2012, 2020 &
2027

Table 49: China Current & Future Analysis for Osteoarthritis
Therapeutics by Drug Type - Viscosupplementation Agents,
Nonsteroidal Anti-inflammatory Drugs, Analgesics and
Corticosteroids - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 50: China Historic Review for Osteoarthritis Therapeutics
by Drug Type - Viscosupplementation Agents, Nonsteroidal
Anti-inflammatory Drugs, Analgesics and Corticosteroids Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 51: China 15-Year Perspective for Osteoarthritis
Therapeutics by Drug Type - Percentage Breakdown of Value Sales
for Viscosupplementation Agents, Nonsteroidal Anti-inflammatory
Drugs, Analgesics and Corticosteroids for the Years 2012, 2020 &
2027

EUROPE
Table 52: Europe Current & Future Analysis for Osteoarthritis
Therapeutics by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 53: Europe Historic Review for Osteoarthritis
Therapeutics by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 54: Europe 15-Year Perspective for Osteoarthritis
Therapeutics by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK, Spain, Russia and
Rest of Europe Markets for Years 2012, 2020 & 2027

Table 55: Europe Current & Future Analysis for Osteoarthritis
Therapeutics by Anatomy - Knee, Hip, Hand and Small Joints -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 56: Europe Historic Review for Osteoarthritis
Therapeutics by Anatomy - Knee, Hip, Hand and Small Joints
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 57: Europe 15-Year Perspective for Osteoarthritis
Therapeutics by Anatomy - Percentage Breakdown of Value Sales
for Knee, Hip, Hand and Small Joints for the Years 2012, 2020 &
2027

Table 58: Europe Current & Future Analysis for Osteoarthritis
Therapeutics by Drug Type - Viscosupplementation Agents,
Nonsteroidal Anti-inflammatory Drugs, Analgesics and
Corticosteroids - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 59: Europe Historic Review for Osteoarthritis
Therapeutics by Drug Type - Viscosupplementation Agents,
Nonsteroidal Anti-inflammatory Drugs, Analgesics and
Corticosteroids Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 60: Europe 15-Year Perspective for Osteoarthritis
Therapeutics by Drug Type - Percentage Breakdown of Value Sales
for Viscosupplementation Agents, Nonsteroidal Anti-inflammatory
Drugs, Analgesics and Corticosteroids for the Years 2012, 2020 &
2027

FRANCE
Table 61: France Current & Future Analysis for Osteoarthritis
Therapeutics by Anatomy - Knee, Hip, Hand and Small Joints -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 62: France Historic Review for Osteoarthritis
Therapeutics by Anatomy - Knee, Hip, Hand and Small Joints
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 63: France 15-Year Perspective for Osteoarthritis
Therapeutics by Anatomy - Percentage Breakdown of Value Sales
for Knee, Hip, Hand and Small Joints for the Years 2012, 2020 &
2027

Table 64: France Current & Future Analysis for Osteoarthritis
Therapeutics by Drug Type - Viscosupplementation Agents,
Nonsteroidal Anti-inflammatory Drugs, Analgesics and
Corticosteroids - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 65: France Historic Review for Osteoarthritis
Therapeutics by Drug Type - Viscosupplementation Agents,
Nonsteroidal Anti-inflammatory Drugs, Analgesics and
Corticosteroids Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 66: France 15-Year Perspective for Osteoarthritis
Therapeutics by Drug Type - Percentage Breakdown of Value Sales
for Viscosupplementation Agents, Nonsteroidal Anti-inflammatory
Drugs, Analgesics and Corticosteroids for the Years 2012, 2020 &
2027

GERMANY
Table 67: Germany Current & Future Analysis for Osteoarthritis
Therapeutics by Anatomy - Knee, Hip, Hand and Small Joints -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 68: Germany Historic Review for Osteoarthritis
Therapeutics by Anatomy - Knee, Hip, Hand and Small Joints
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 69: Germany 15-Year Perspective for Osteoarthritis
Therapeutics by Anatomy - Percentage Breakdown of Value Sales
for Knee, Hip, Hand and Small Joints for the Years 2012, 2020 &
2027

Table 70: Germany Current & Future Analysis for Osteoarthritis
Therapeutics by Drug Type - Viscosupplementation Agents,
Nonsteroidal Anti-inflammatory Drugs, Analgesics and
Corticosteroids - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 71: Germany Historic Review for Osteoarthritis
Therapeutics by Drug Type - Viscosupplementation Agents,
Nonsteroidal Anti-inflammatory Drugs, Analgesics and
Corticosteroids Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 72: Germany 15-Year Perspective for Osteoarthritis
Therapeutics by Drug Type - Percentage Breakdown of Value Sales
for Viscosupplementation Agents, Nonsteroidal Anti-inflammatory
Drugs, Analgesics and Corticosteroids for the Years 2012, 2020 &
2027

ITALY
Table 73: Italy Current & Future Analysis for Osteoarthritis
Therapeutics by Anatomy - Knee, Hip, Hand and Small Joints -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 74: Italy Historic Review for Osteoarthritis Therapeutics
by Anatomy - Knee, Hip, Hand and Small Joints Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 75: Italy 15-Year Perspective for Osteoarthritis
Therapeutics by Anatomy - Percentage Breakdown of Value Sales
for Knee, Hip, Hand and Small Joints for the Years 2012, 2020 &
2027

Table 76: Italy Current & Future Analysis for Osteoarthritis
Therapeutics by Drug Type - Viscosupplementation Agents,
Nonsteroidal Anti-inflammatory Drugs, Analgesics and
Corticosteroids - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 77: Italy Historic Review for Osteoarthritis Therapeutics
by Drug Type - Viscosupplementation Agents, Nonsteroidal
Anti-inflammatory Drugs, Analgesics and Corticosteroids Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 78: Italy 15-Year Perspective for Osteoarthritis
Therapeutics by Drug Type - Percentage Breakdown of Value Sales
for Viscosupplementation Agents, Nonsteroidal Anti-inflammatory
Drugs, Analgesics and Corticosteroids for the Years 2012, 2020 &
2027

UNITED KINGDOM
Table 79: UK Current & Future Analysis for Osteoarthritis
Therapeutics by Anatomy - Knee, Hip, Hand and Small Joints -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 80: UK Historic Review for Osteoarthritis Therapeutics by
Anatomy - Knee, Hip, Hand and Small Joints Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 81: UK 15-Year Perspective for Osteoarthritis
Therapeutics by Anatomy - Percentage Breakdown of Value Sales
for Knee, Hip, Hand and Small Joints for the Years 2012, 2020 &
2027

Table 82: UK Current & Future Analysis for Osteoarthritis
Therapeutics by Drug Type - Viscosupplementation Agents,
Nonsteroidal Anti-inflammatory Drugs, Analgesics and
Corticosteroids - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 83: UK Historic Review for Osteoarthritis Therapeutics by
Drug Type - Viscosupplementation Agents, Nonsteroidal
Anti-inflammatory Drugs, Analgesics and Corticosteroids Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 84: UK 15-Year Perspective for Osteoarthritis
Therapeutics by Drug Type - Percentage Breakdown of Value Sales
for Viscosupplementation Agents, Nonsteroidal Anti-inflammatory
Drugs, Analgesics and Corticosteroids for the Years 2012, 2020 &
2027

SPAIN
Table 85: Spain Current & Future Analysis for Osteoarthritis
Therapeutics by Anatomy - Knee, Hip, Hand and Small Joints -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 86: Spain Historic Review for Osteoarthritis Therapeutics
by Anatomy - Knee, Hip, Hand and Small Joints Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 87: Spain 15-Year Perspective for Osteoarthritis
Therapeutics by Anatomy - Percentage Breakdown of Value Sales
for Knee, Hip, Hand and Small Joints for the Years 2012, 2020 &
2027

Table 88: Spain Current & Future Analysis for Osteoarthritis
Therapeutics by Drug Type - Viscosupplementation Agents,
Nonsteroidal Anti-inflammatory Drugs, Analgesics and
Corticosteroids - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 89: Spain Historic Review for Osteoarthritis Therapeutics
by Drug Type - Viscosupplementation Agents, Nonsteroidal
Anti-inflammatory Drugs, Analgesics and Corticosteroids Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 90: Spain 15-Year Perspective for Osteoarthritis
Therapeutics by Drug Type - Percentage Breakdown of Value Sales
for Viscosupplementation Agents, Nonsteroidal Anti-inflammatory
Drugs, Analgesics and Corticosteroids for the Years 2012, 2020 &
2027

RUSSIA
Table 91: Russia Current & Future Analysis for Osteoarthritis
Therapeutics by Anatomy - Knee, Hip, Hand and Small Joints -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 92: Russia Historic Review for Osteoarthritis
Therapeutics by Anatomy - Knee, Hip, Hand and Small Joints
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 93: Russia 15-Year Perspective for Osteoarthritis
Therapeutics by Anatomy - Percentage Breakdown of Value Sales
for Knee, Hip, Hand and Small Joints for the Years 2012, 2020 &
2027

Table 94: Russia Current & Future Analysis for Osteoarthritis
Therapeutics by Drug Type - Viscosupplementation Agents,
Nonsteroidal Anti-inflammatory Drugs, Analgesics and
Corticosteroids - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 95: Russia Historic Review for Osteoarthritis
Therapeutics by Drug Type - Viscosupplementation Agents,
Nonsteroidal Anti-inflammatory Drugs, Analgesics and
Corticosteroids Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 96: Russia 15-Year Perspective for Osteoarthritis
Therapeutics by Drug Type - Percentage Breakdown of Value Sales
for Viscosupplementation Agents, Nonsteroidal Anti-inflammatory
Drugs, Analgesics and Corticosteroids for the Years 2012, 2020 &
2027

REST OF EUROPE
Table 97: Rest of Europe Current & Future Analysis for
Osteoarthritis Therapeutics by Anatomy - Knee, Hip, Hand and
Small Joints - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 98: Rest of Europe Historic Review for Osteoarthritis
Therapeutics by Anatomy - Knee, Hip, Hand and Small Joints
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 99: Rest of Europe 15-Year Perspective for Osteoarthritis
Therapeutics by Anatomy - Percentage Breakdown of Value Sales
for Knee, Hip, Hand and Small Joints for the Years 2012, 2020 &
2027

Table 100: Rest of Europe Current & Future Analysis for
Osteoarthritis Therapeutics by Drug Type - Viscosupplementation
Agents, Nonsteroidal Anti-inflammatory Drugs, Analgesics and
Corticosteroids - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 101: Rest of Europe Historic Review for Osteoarthritis
Therapeutics by Drug Type - Viscosupplementation Agents,
Nonsteroidal Anti-inflammatory Drugs, Analgesics and
Corticosteroids Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 102: Rest of Europe 15-Year Perspective for
Osteoarthritis Therapeutics by Drug Type - Percentage Breakdown
of Value Sales for Viscosupplementation Agents, Nonsteroidal
Anti-inflammatory Drugs, Analgesics and Corticosteroids for the
Years 2012, 2020 & 2027

ASIA-PACIFIC
Table 103: Asia-Pacific Current & Future Analysis for
Osteoarthritis Therapeutics by Geographic Region - Australia,
India, South Korea and Rest of Asia-Pacific Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 104: Asia-Pacific Historic Review for Osteoarthritis
Therapeutics by Geographic Region - Australia, India, South
Korea and Rest of Asia-Pacific Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 105: Asia-Pacific 15-Year Perspective for Osteoarthritis
Therapeutics by Geographic Region - Percentage Breakdown of
Value Sales for Australia, India, South Korea and Rest of
Asia-Pacific Markets for Years 2012, 2020 & 2027

Table 106: Asia-Pacific Current & Future Analysis for
Osteoarthritis Therapeutics by Anatomy - Knee, Hip, Hand and
Small Joints - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 107: Asia-Pacific Historic Review for Osteoarthritis
Therapeutics by Anatomy - Knee, Hip, Hand and Small Joints
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 108: Asia-Pacific 15-Year Perspective for Osteoarthritis
Therapeutics by Anatomy - Percentage Breakdown of Value Sales
for Knee, Hip, Hand and Small Joints for the Years 2012, 2020 &
2027

Table 109: Asia-Pacific Current & Future Analysis for
Osteoarthritis Therapeutics by Drug Type - Viscosupplementation
Agents, Nonsteroidal Anti-inflammatory Drugs, Analgesics and
Corticosteroids - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 110: Asia-Pacific Historic Review for Osteoarthritis
Therapeutics by Drug Type - Viscosupplementation Agents,
Nonsteroidal Anti-inflammatory Drugs, Analgesics and
Corticosteroids Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 111: Asia-Pacific 15-Year Perspective for Osteoarthritis
Therapeutics by Drug Type - Percentage Breakdown of Value Sales
for Viscosupplementation Agents, Nonsteroidal Anti-inflammatory
Drugs, Analgesics and Corticosteroids for the Years 2012, 2020 &
2027

AUSTRALIA
Table 112: Australia Current & Future Analysis for
Osteoarthritis Therapeutics by Anatomy - Knee, Hip, Hand and
Small Joints - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 113: Australia Historic Review for Osteoarthritis
Therapeutics by Anatomy - Knee, Hip, Hand and Small Joints
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 114: Australia 15-Year Perspective for Osteoarthritis
Therapeutics by Anatomy - Percentage Breakdown of Value Sales
for Knee, Hip, Hand and Small Joints for the Years 2012, 2020 &
2027

Table 115: Australia Current & Future Analysis for
Osteoarthritis Therapeutics by Drug Type - Viscosupplementation
Agents, Nonsteroidal Anti-inflammatory Drugs, Analgesics and
Corticosteroids - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 116: Australia Historic Review for Osteoarthritis
Therapeutics by Drug Type - Viscosupplementation Agents,
Nonsteroidal Anti-inflammatory Drugs, Analgesics and
Corticosteroids Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 117: Australia 15-Year Perspective for Osteoarthritis
Therapeutics by Drug Type - Percentage Breakdown of Value Sales
for Viscosupplementation Agents, Nonsteroidal Anti-inflammatory
Drugs, Analgesics and Corticosteroids for the Years 2012, 2020 &
2027

INDIA
Table 118: India Current & Future Analysis for Osteoarthritis
Therapeutics by Anatomy - Knee, Hip, Hand and Small Joints -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 119: India Historic Review for Osteoarthritis
Therapeutics by Anatomy - Knee, Hip, Hand and Small Joints
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 120: India 15-Year Perspective for Osteoarthritis
Therapeutics by Anatomy - Percentage Breakdown of Value Sales
for Knee, Hip, Hand and Small Joints for the Years 2012, 2020 &
2027

Table 121: India Current & Future Analysis for Osteoarthritis
Therapeutics by Drug Type - Viscosupplementation Agents,
Nonsteroidal Anti-inflammatory Drugs, Analgesics and
Corticosteroids - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 122: India Historic Review for Osteoarthritis
Therapeutics by Drug Type - Viscosupplementation Agents,
Nonsteroidal Anti-inflammatory Drugs, Analgesics and
Corticosteroids Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 123: India 15-Year Perspective for Osteoarthritis
Therapeutics by Drug Type - Percentage Breakdown of Value Sales
for Viscosupplementation Agents, Nonsteroidal Anti-inflammatory
Drugs, Analgesics and Corticosteroids for the Years 2012, 2020 &
2027

SOUTH KOREA
Table 124: South Korea Current & Future Analysis for
Osteoarthritis Therapeutics by Anatomy - Knee, Hip, Hand and
Small Joints - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 125: South Korea Historic Review for Osteoarthritis
Therapeutics by Anatomy - Knee, Hip, Hand and Small Joints
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 126: South Korea 15-Year Perspective for Osteoarthritis
Therapeutics by Anatomy - Percentage Breakdown of Value Sales
for Knee, Hip, Hand and Small Joints for the Years 2012, 2020 &
2027

Table 127: South Korea Current & Future Analysis for
Osteoarthritis Therapeutics by Drug Type - Viscosupplementation
Agents, Nonsteroidal Anti-inflammatory Drugs, Analgesics and
Corticosteroids - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 128: South Korea Historic Review for Osteoarthritis
Therapeutics by Drug Type - Viscosupplementation Agents,
Nonsteroidal Anti-inflammatory Drugs, Analgesics and

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06032411/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001